MAPK3 and neuroblastoma: To further investigate the increase of Erk1/Erk2 phosporylation in sunitinib-treated neuroblastoma cells, we incubated SK-N-BE(2) cells with increasing doses of the MEK1 inhibitor PD98059, sunitinib or a combination of both drugs for 72 h.